Inactive Instrument

SoftOx Solutions AS Stock Oslo Bors

Equities

NO0010811961

Biotechnology & Medical Research

Financials

Sales 2021 7.9M 718K 972K Sales 2022 7.11M 647K 875K Capitalization 241M 21.91M 29.64M
Net income 2021 -65M -5.91M -8M Net income 2022 -71M -6.45M -8.73M EV / Sales 2021 64.3 x
Net cash position 2021 56.98M 5.18M 7.01M Net cash position 2022 6.91M 628K 850K EV / Sales 2022 32.9 x
P/E ratio 2021
-8.86 x
P/E ratio 2022
-3.39 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 96.54%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on SoftOx Solutions AS

Managers TitleAgeSince
Chief Executive Officer - -
Founder - 12-06-20
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member - 15-04-16
Founder - 12-06-20
Director/Board Member - -
More insiders
SoftOx Solutions AS is a Norway-based medtech and biotech company, that develops products to help fight infections from viruses, biofilm resistance and antimicrobial resistance. It is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The Company has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
More about the company